Tyra Biosciences (TYRA) Non-cash Items (2021 - 2026)
Quarterly Non-cash Items fell 89.75% to $6.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Mar 2026, down 89.75% year-over-year, with the annual reading at $186.7 million for FY2025, 452.31% up from the prior year.
Tyra Biosciences filings provide 6 years of Non-cash Items readings, the most recent being $6.0 million for Q1 2026.
- Non-cash Items hit $6.0 million in Q1 2026 for Tyra Biosciences, down from $186.7 million in the prior quarter.
- Across five years, Non-cash Items topped out at $186.7 million in Q4 2025 and bottomed at $1.3 million in Q3 2022.
- Average Non-cash Items over 5 years is $29.6 million, with a median of $13.5 million recorded in 2022.
- Peak annual rise in Non-cash Items hit 3250.14% in 2023, while the deepest fall reached 91.94% in 2023.
- Tyra Biosciences' Non-cash Items stood at $13.5 million in 2022, then surged by 199.58% to $40.4 million in 2023, then decreased by 16.38% to $33.8 million in 2024, then soared by 452.31% to $186.7 million in 2025, then crashed by 96.8% to $6.0 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Non-cash Items are $6.0 million (Q1 2026), $186.7 million (Q4 2025), and $6.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.97 Mn |
| Mar 31, 2026 | 5.97 Mn |
| Dec 31, 2025 | 186.67 Mn |
| Dec 31, 2025 | 186.67 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 5.46 Mn |
| Mar 31, 2025 | 58.30 Mn |
| Mar 31, 2025 | 58.30 Mn |
| Dec 31, 2024 | 33.80 Mn |
| Dec 31, 2024 | 33.80 Mn |
| Sep 30, 2024 | 4.51 Mn |
| Sep 30, 2024 | 4.51 Mn |
| Jun 30, 2024 | 50.37 Mn |
| Jun 30, 2024 | 50.37 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Mar 31, 2024 | 3.66 Mn |
| Dec 31, 2023 | 40.42 Mn |
| Dec 31, 2023 | 40.42 Mn |
| Sep 30, 2023 | 42.30 Mn |
| Sep 30, 2023 | 42.30 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Jun 30, 2023 | 2.21 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.98 Mn |
| Dec 31, 2022 | 13.49 Mn |
| Dec 31, 2022 | 13.49 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 21.80 Mn |
| Jun 30, 2022 | 21.80 Mn |
| Mar 31, 2022 | 24.50 Mn |
| Mar 31, 2022 | 24.50 Mn |
| Dec 31, 2021 | 28.90 Mn |
| Dec 31, 2021 | 28.90 Mn |
| Sep 30, 2021 | 5.40 Mn |
| Sep 30, 2021 | 5.40 Mn |